2096
COM:SIMCERE
Simcere Pharmaceutical Group
- Stock
Last Close
6.78
22/11 08:08
Market Cap
14.37B
Beta: -
Volume Today
3.31M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 210.56M - | 241.02M 14.47% | 255.42M 5.98% | 248.91M 2.55% | 268.76M 7.97% | 458.47M 70.58% | ||
average payables | 261.33M - | 281.20M 7.61% | 248.46M 11.64% | 283.01M 13.91% | 329.20M 16.32% | 325.83M 1.02% | ||
average receivables | 2.49B - | |||||||
book value per share | 0.68 - | 0.60 12.03% | 0.57 5.41% | 2.03 257.71% | 2.47 21.41% | 2.73 10.61% | 2.73 0.04% | |
capex per share | -0.11 - | -0.13 14.72% | -0.19 51.44% | -0.14 30.58% | -0.08 40.63% | -0.26 223.34% | ||
capex to depreciation | -2.81 - | -2.79 0.44% | -3.12 11.83% | -1.59 49.20% | -0.83 47.58% | -2.40 188.05% | ||
capex to operating cash flow | -0.31 - | -0.43 38.86% | -0.66 52.03% | -3.65 455.28% | 1.04 128.44% | -0.50 148.25% | ||
capex to revenue | -0.08 - | -0.07 1.70% | -0.10 35.73% | -0.08 22.36% | -0.04 46.46% | -0.11 156.07% | ||
cash per share | 0.42 - | 0.56 34.14% | 0.35 37.85% | 1.26 262.63% | 0.84 33.31% | 1.00 19.97% | 0.76 24.07% | |
days of inventory on hand | 116.57 - | 110.69 5.04% | 101.95 7.89% | 106.54 4.50% | 79.48 25.40% | 83.47 5.02% | 138.15 65.52% | |
days payables outstanding | 133.91 - | 145.56 8.70% | 104.70 28.08% | 98.18 6.22% | 109.49 11.51% | 92.32 15.68% | 71.31 22.76% | |
days sales outstanding | 146.08 - | |||||||
debt to assets | 0.25 - | 0.37 44.18% | 0.43 18.85% | 0.30 30.62% | 0.16 46.61% | 0.14 13.19% | 0.12 11.04% | |
debt to equity | 0.74 - | 1.48 99.97% | 1.99 34.14% | 0.62 68.67% | 0.25 59.17% | 0.21 16.81% | 0.19 11.63% | |
dividend yield | 0.02 - | 0.04 62.17% | 0.02 - | 0.01 28.64% | ||||
earnings yield | 0.01 - | 0.03 99.24% | 0.04 33.55% | 0.03 13.72% | 0.08 129.99% | 0.03 55.84% | 0.05 31.78% | |
enterprise value | 24.45B - | 26.04B 6.51% | 28.10B 7.92% | 19.76B 29.69% | 19.97B 1.08% | 26.91B 34.73% | 15.08B 43.97% | |
enterprise value over ebitda | 29.62 - | 25.64 13.45% | 20.93 18.35% | 25.08 19.80% | 21.25 15.24% | 24.71 16.26% | 16.03 35.14% | |
ev to operating cash flow | 26.04 - | 33.57 28.92% | 36.37 8.34% | 204.28 461.71% | -98.89 148.41% | 19.86 120.09% | ||
ev to sales | 6.32 - | 5.77 8.74% | 5.58 3.28% | 4.38 21.46% | 3.99 8.85% | 4.26 6.60% | 2.28 46.42% | |
free cash flow per share | 0.25 - | 0.17 31.89% | 0.10 39.82% | -0.10 196.48% | -0.16 60.66% | 0.26 264.31% | ||
free cash flow yield | 0.03 - | 0.02 35.19% | 0.01 41.25% | -0.01 224.93% | -0.02 64.15% | 0.03 217.36% | ||
graham net net | -0.86 - | -1.23 43.19% | -1.64 32.92% | -0.84 48.36% | -0.54 36.54% | -0.33 38.15% | 0.26 177.30% | |
graham number | 1.44 - | 1.95 35.72% | 2.22 13.75% | 3.43 54.39% | 5.66 65.32% | 4.68 17.30% | 4.07 13.08% | |
income quality | 1.89 - | 0.84 55.78% | 0.71 14.46% | 0.12 83.18% | -0.14 219.92% | 1.53 1,158.66% | ||
intangibles to total assets | 0.04 - | 0.03 24.55% | 0.03 13.94% | 0.02 12.32% | 0.02 0.19% | 0.05 124.06% | 0.08 54.25% | |
interest coverage | 9.08 - | 19.82 118.27% | 10.10 49.02% | 4.23 58.13% | 9.71 129.54% | 25.07 158.17% | ||
interest debt per share | 0.53 - | 0.91 71.90% | 1.17 29.23% | 1.32 12.20% | 0.65 50.30% | 0.59 9.79% | 0.51 13.64% | |
inventory turnover | 3.13 - | 3.30 5.31% | 3.58 8.57% | 3.43 4.30% | 4.59 34.05% | 4.37 4.78% | 2.64 39.58% | |
invested capital | 0.74 - | 1.48 99.97% | 1.99 34.14% | 0.62 68.67% | 0.25 59.17% | 0.21 16.81% | 0.19 11.63% | |
market cap | 23.71B - | 24.91B 5.09% | 25.52B 2.43% | 19.73B 22.68% | 19.31B 2.13% | 27.06B 40.14% | 15.74B 41.85% | |
net current asset value | -629.84M - | -1.11B 75.85% | -2.39B 115.68% | 859.15M 135.97% | 1.28B 49.12% | 1.82B 41.71% | 2.01B 10.60% | |
net debt to ebitda | 0.90 - | 1.11 23.27% | 1.93 73.13% | 0.04 98.04% | 0.71 1,766.36% | -0.14 119.64% | -0.70 404.74% | |
net income per share | 0.13 - | 0.28 109.38% | 0.39 36.79% | 0.26 33.36% | 0.58 125.10% | 0.36 38.17% | 0.27 24.42% | |
operating cash flow per share | 0.36 - | 0.30 17.39% | 0.30 0.39% | 0.04 87.50% | -0.08 308.80% | 0.52 770.10% | ||
payables turnover | 2.73 - | 2.51 8.01% | 3.49 39.04% | 3.72 6.63% | 3.33 10.32% | 3.95 18.59% | 5.12 29.46% | |
receivables turnover | 2.50 - | |||||||
research and ddevelopement to revenue | 0.05 - | 0.10 80.46% | 0.14 43.60% | 0.25 78.07% | 0.28 11.87% | 0.27 3.48% | 0.24 13.51% | |
return on tangible assets | 0.07 - | 0.12 69.87% | 0.15 27.57% | 0.06 58.88% | 0.15 142.44% | 0.09 39.92% | 0.07 21.59% | |
revenue per share | 1.48 - | 1.73 16.71% | 1.93 11.57% | 1.73 10.58% | 1.92 10.89% | 2.42 26.27% | 2.50 3.14% | |
roe | 0.20 - | 0.47 138.01% | 0.68 44.62% | 0.13 81.37% | 0.23 85.40% | 0.13 44.10% | 0.10 24.39% | |
roic | 0.12 - | 0.19 57.69% | 0.24 25.68% | 0.05 77.73% | 0.09 70.21% | 0.10 13.33% | 0.08 19.12% | |
sales general and administrative to revenue | 0.03 - | 0.03 12.41% | 0.03 1.49% | 0.09 222.34% | 0.08 16.17% | 0.07 8.11% | 0.08 7.49% | |
shareholders equity per share | 0.68 - | 0.60 12.03% | 0.57 5.41% | 2.03 257.71% | 2.47 21.41% | 2.73 10.61% | 2.73 0.04% | |
stock based compensation to revenue | 0.00 - | 0.00 67.79% | 0.00 122.71% | 0.01 158.90% | 0.01 71.55% | 0.02 75.37% | 0.00 91.62% | |
tangible asset value | 1.57B - | 1.37B 12.68% | 1.30B 5.03% | 5.09B 289.95% | 6.23B 22.50% | 6.59B 5.78% | 6.36B 3.42% | |
tangible book value per share | 0.60 - | 0.53 12.68% | 0.50 5.03% | 1.95 289.51% | 2.39 22.50% | 2.52 5.67% | 2.40 4.74% | |
working capital | 252.23M - | -445.77M 276.73% | -530.86M 19.09% | 2.97B 659.40% | 1.92B 35.49% | 2.49B 29.98% | 2.95B 18.59% |
All numbers in (except ratios and percentages)